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Sanger sequencing has been the major method in directly sequencing DNA, and has dominated the DNA sequencing market for 
nearly past 30 years (Varshney et al., 2009). Along with PCR, we cannot underestimate how important this technology has been to 
research in various  elds of molecular biology. It has revolutionized genetics by allowing us to gain unprecedented insights into the 
workings of different organisms.  
Sanger method is considered the  rst generation technology. The technology has been considered rather static with the main change 
being in the increase in number of samples that could be analyzed during any one machine run. However, the length of reads per run 
remains about the same. Its limitations include maximum read length usually < 1000 bp, extremely high cost, long experimental set up 
times, high DNA concentrations needed and some regions are unsequenceable.  If we only use this technology to sequence human DNA, 
it would take 30 years and cost more than RM25 million (Veeramah, 2009). Major accomplishment of the technology is the human 
genome sequence through the much-publicised Human Genome Project which took 13 years and about USD3.0 billion to accomplish. 
NGST PLATFORMS
The limitations of Sanger sequencing has led to the development of newer technology platforms. Research nowadays has a niche 
for developing higher throughput technology. Newer technologies, a.k.a. next generation sequencing technologies (NGST), have 
been developed to substantially increase the productivity, decrease the cost of DNA sequencing, and offer fast and accurate genome 
information.  These technologies are able to produce billions of data up to 1 Gb of short reads per instrument run in a high-throughput 
and cost-effective fashion in contrast to  rst generation technology (conventional method) which only produces Mb of data.
The bulk of these technology platforms that are currently available share common elements which can be best described by the 
term sequencing by synthesis. In these platforms, each single DNA molecule is replicated many 1,000 times, made single-stranded, 
 xed to a speci c location, and then sequenced by using a DNA polymerase-based method. The latter is much the same way as Sanger 
method; however, newer technologies differ on how DNA is  xed, and what particular next generation sequencing (NGS) chemistry is 
used to get the required reaction. Table 1 describes the major next generation sequencing technologies that are commercially available 
and have been taken up by many institutions. Examples of commercially available NGS technologies include Illumina/Solexa GAII, 
Roche 454 GS FLX Titanium, LifeTech/APG SOLiD 3 System, Helicos BioSciences HeliScope, Dover Systems Polonator G.007 and 
Paci c Biosciences DNA sequencing instrument.  Illumina/Solexa is currently the most widely used in the  eld. Many have already 
demonstrated their potential to circumvent the limiting factors of Sanger sequencing. 
Table 1 : Major next generation sequencing technologies that are commercially available and have been taken up by many institutions









































RTs 32 8 37 2,997,000 No bias 
representation of 
templates
High error rates 
compared with 
other RTs
Paci c Biosciences 
DNA sequencing 
instrument
Realtime 964 - - - Has potential to 
read > 1 kb
Highest error 
rates compared 
with other NGS 
technologies
